北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (3): 470-478. doi: 10.19723/j.issn.1671-167X.2020.03.012

• 论著 • 上一篇    下一篇

孕早期血清维生素E水平与妊娠期高血压疾病发病风险的关系

孟文颖1,黄琬桐2,张杰2,焦明远3,金蕾4,靳蕾2,()   

  1. 1. 北京市通州区妇幼保健院产科,北京 101100
    2. 北京大学生育健康研究所,国家卫生健康委员会生育健康重点实验室,北京大学公共卫生学院流行病与卫生统计学系,北京 100191
    3. 北京市通州区妇幼保健院检验科,北京 101100
    4. 北京市通州区妇幼保健院妇女保健科,北京 101100
  • 收稿日期:2020-02-16 出版日期:2020-06-18 发布日期:2020-06-30
  • 通讯作者: 靳蕾 E-mail:songyi@bjmu.edu.cn
  • 基金资助:
    国家重点研发计划(2018YFC1004301)

Relationship between serum vitamin E concentration in first trimester and the risk of developing hypertension disorders complicating pregnancy

Wen-ying MENG1,Wan-tong HUANG2,Jie ZHANG2,Ming-yuan JIAO3,Lei JIN4,Lei JIN2,()   

  1. 1. Department of Obstetrics, Tongzhou Maternal & Child Health Hospital of Beijing, Beijing 101100, China
    2. Institute of Reproductive and Child Health, National Health Commission Key Laboratory of Reproductive Health, Peking University, Beijing 100191, China; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
    3. Department of Clinical Laboratory, Tongzhou Maternal & Child Health Hospital of Beijing, Beijing 101100, China
    4. Department of Maternal Health Care, Tongzhou Maternal & Child Health Hospital of Beijing, Beijing 101100, China
  • Received:2020-02-16 Online:2020-06-18 Published:2020-06-30
  • Contact: Lei JIN E-mail:songyi@bjmu.edu.cn
  • Supported by:
    National Key R&D Program of China(2018YFC1004301)

摘要:

目的 了解北京妇女妊娠期高血压疾病(hypertension disorders complicating pregnancy, HDCP)发病率和孕早期维生素E(vitamin E, VE)营养状况,探究孕早期血清VE浓度与HDCP发病率的关系。方法 以北京市通州区孕期保健系统和通州区妇幼保健院医院信息系统为基础,利用2016年1月至 2018年12月在北京市通州区妇幼保健院分娩并在孕早期测定了血清VE浓度的22 283名单胎孕产妇的信息进行回顾性队列研究,用非条件Logistic回归模型分析不同血清VE浓度与HDCP发病风险的关系。结果 HDCP总发病率为5.4%,其中妊娠期高血压发病率为2.1%,子痫前期-子痫发病率为3.3%。妇女孕早期血清VE浓度中位值为10.1(8.8 ~ 11.6) mg/L,99.7%的妇女孕早期血清VE水平处于正常参考值范围内。3年间,妇女孕早期血清VE浓度(P < 0.001)及HDCP的发病率(P = 0.005)均有逐年上升趋势。单因素与多因素Logistic回归分析结果显示,血清VE浓度较高的孕妇HDCP的发病风险更高;在多因素Logistic回归分析中,与血清VE浓度在百分位数 P 25 ~ P75范围内的孕妇相比,血清VE浓度高于P75的孕妇HDCP(OR = 1.34,P < 0.001)、妊娠期高血压(OR = 1.39,P = 0.002)和子痫前期-子痫(OR = 1.34,P = 0.001)的发病风险均较高。与血清VE浓度在百分位数P40 ~ P60范围内的孕妇相比,当血清VE浓度达到11.2 mg/L时,HDCP的发病风险显著升高,且随着血清VE浓度的升高而升高。 结论 北京地区妊娠妇女孕早期VE营养状况良好,孕早期血清VE浓度高与妇女HDCP发病率相关,可以预示HDCP发生风险升高的孕早期血清维生素E浓度的临界值可能是11.2 mg/L,提示妊娠妇女应慎重服用含有VE的营养补充剂。

关键词: 高血压, 子痫, 妊娠, 维生素E, 队列研究

Abstract:

Objective: To investigate the incidence of hypertension disorders complicating pregnancy (HDCP) and vitamin E (VE) nutritional status among pregnant women in Beijing, and to determine the relationship between serum VE concentration in the first trimester of pregnancy and the risk of developing HDCP.Methods: A retrospective cohort study was performed including 22 283 cases of pregnant women who underwent singleton deliveries in Tongzhou Maternal & Child Health Hospital of Beijing from January 2016 through December 2018 and received tests of serum VE concentrations in the first trimester of pregnancy. Nonconditional Logistic regression model was used to analyze the association between serum VE concentration levels and the risk of developing HDCP.Results: The total incidence of HDCP was 5.4%, with the incidence of gestational hypertension around 2.1% and the incidence of preeclampsia-eclampsia around 3.3%. The median concentration of serum VE in early pregnancy was 10.1 (8.8-11.6) mg/L, and 99.7% of the participants had normal serum VE concentrations. The incidence of gestational hypertension and that of preeclampsia-eclampsia had been annually increasing in three years; a linear-by-linear association had also been observed between the serum VE concentrations and the years of delivery. According to the results of the univariable and the multivariable Logistic regression analyses, higher risks of developing HDCP had been observed among women with higher serum VE concentrations. Compared to those with serum VE concentrations in interquartile range (P25-P75) of all the participants, the women whose serum VE concentrations above P75 were at higher risks to be attacked by HDCP (OR = 1.34, P < 0.001), gestational hypertension (OR = 1.39, P = 0.002), or preeclampsia-eclampsia (OR = 1.34, P = 0.001), as suggested by the results of the multivariable Logistic regression model analyses. In addition, the women with serum VE concentrations of 11.2 mg/L or above had a significantly higher risk of developing HDCP than those whose serum VE concentrations of P40-P60 of all the participants, and this risk grew higher as serum VE concentrations in the first trimester of pregnancy increased.Conclusion: Women in Beijing are at good nutritional status. From January 2016 to December 2018, the incidence of HDCP increased with serum VE concentration level, and serum VE concentration of 11.2 mg/L is an indicator of an increased risk of developing HDCP, suggesting that pregnant women should take nutritional supplements containing VE carefully.

Key words: Hypertension, Eclampsia, Pregnancy, Vitamin E, Cohort study

中图分类号: 

  • R172

图1

研究对象纳入与排除流程图"

表1

不同VE营养状况研究对象的基本特征"

Characteristics Total number
(n = 22 283),
n (%)
VE normala
(n = 22 206),
n (%)
VE deficienta
(n = 13),
n (%)
VE excessivea
(n = 64),
n (%)
P
Delivery year
2016 7 216 (32.4) 7 194 (32.4) 10 (76.9) 12 (18.8) 0.001b
2017 7 677 (34.5) 7 653 (34.5) 1 (7.7) 23 (35.9)
2018 7 390 (33.2) 7 359 (33.1) 2 (15.4) 29 (45.3)
Maternal age/years
17 - 1 996 (9.0) 1 988 (9.0) 4 (30.8) 4 (6.3) 0.001b
25 - 10 501 (47.1) 10 476 (47.2) 6 (46.2) 19 (29.7)
30 - 7 313 (32.8) 7 287 (32.8) 2 (15.4) 24 (37.5)
35 - 51 2 473 (11.1) 2 455 (11.1) 1 (7.7) 17 (26.6)
Ethnic
Han 20 959 (94.1) 20 885 (94.1) 12 (92.3) 62 (96.9) 0.523b
Others 1 324 (5.9) 1 321 (5.9) 1 (7.7) 2 (3.1)
Education level
Middle school or lower 1 905 (8.5) 1 902 (8.6) 2 (15.4) 1 (1.6) 0.080b
High school or secondary technical school 4 219 (18.9) 4 199 (18.9) 4 (30.8) 16 (25.0)
College 7 168 (32.2) 7 140 (32.2) 5 (38.5) 23 (35.9)
University or above 8 991 (40.3) 8 965 (40.4) 2 (15.4) 24 (37.5)
Pre-pregnant BMI
Normal 14 079 (63.2) 14 046 (63.3) 9 (69.2) 24 (37.5) <0.001b
Underweight 2 340 (10.5) 2 334 (10.5) 2 (15.4) 4 (6.3)
Overweight 4 501 (20.2) 4 473 (20.1) 2 (15.4) 26 (40.6)
Obesity 1 363 (6.1) 1 353 (6.1) 0 (0.0) 10 (15.6)
Parity
Nulliparity 12 039 (54.0) 11 996 (54.0) 7 (53.8) 36 (56.3) 0.957
Multiparity 10 244 (46.0) 10 210 (46.0) 6 (46.2) 28 (43.8)
Family history of hypertension
No 21 337 (95.8) 21 261 (95.7) 13 (100.0) 63 (98.4) 0.731b
Yes 946 (4.2) 945 (4.3) 0 (0.0) 1 (1.6)
Family history of diabetes
No 21 871 (98.2) 21 795 (98.1) 13 (100.0) 63 (98.4) 1.000 b
Yes 412 (1.8) 411 (1.9) 0 (0.0) 1 (1.6)

表2

2016年1月至2018年12月研究对象孕早期血清VE水平的变化趋势"

Year of delivery n Median (P25- P75)/
(mg/L)a
Number of women in different serum vitamin E concentration levels, n (%)
< P20 P20- P40 P40- P60 P60- P80 > P80 Pb
2016 7 216 9.7 (8.5-11.2) 1 776 (24.6) 1 573 (21.8) 1 392 (19.3) 1 313 (18.2) 1 162 (16.1) <0.001
2017 7 677 10.2 (9.0-11.8) 1 269 (16.5) 1 500 (19.5) 1 522 (19.8) 1 618 (21.1) 1 768 (23.0)
2018 7 390 10.3 (8.9-11.8) 1 319 (17.8) 1 406 (19.0) 1 383 (18.7) 1 541 (20.9) 1 741 (23.6)
Total 22 283 10.1 (8.8-11.6) 4 364 (19.6) 4 479 (20.1) 4 297 (19.3) 4 472 (20.1) 4 671 (21.0)

表3

2016年1月至2018年12月HDCP发病情况[n(%)]"

Year of delivery n HDCP Gestational hypertension Mild preeclampsia Severe preeclampsia Eclampsia
2016 7 216 345 (4.8) 150 (2.1) 95 (1.3) 100 (1.4) 0 (0.0)
2017 7 677 428 (5.6) 147 (1.9) 152 (2.0) 126 (1.6) 3 (< 0.1)
2018 7 390 432 (5.8) 179 (2.4) 115 (1.6) 136 (1.8) 2 (< 0.1)
Total 22 283 1 205 (5.4) 476 (2.1) 362 (1.6) 362 (1.6) 5 (< 0.1)
χtrend2a - 8.058 2.286 1.420 5.435b
P - 0.005 0.131 0.233 0.020

表4

VE营养状况不同的孕妇HDCP发病情况[n(%)]"

VE nutritional statusa n HDCP Gestational hypertension Mild preeclampsia Severe preeclampsia Eclampsia
Normal 22 206 1 197 (5.4) 472 (2.1) 359 (1.6) 361 (1.6) 5 (< 0.1)
Deficient 13 1 (7.7) 1 (7.7) 0 (0.0) 0 (0.0) 0 (0.0)
Excessive 64 7 (10.9) 3 (4.7) 3 (4.7) 1 (1.6) 0 (0.0)
Total 22 283 1 205 (5.4) 476 (2.1) 362 (1.6) 362 (1.6) 5 (< 0.1)

表5

孕早期血清VE浓度与HDCP发病率的关系"

Outcome VE concentration
levels /(mg/L)
n Incidences,
n (%)
Crude
OR (95%CI)
P Adjusted
OR (95%CI)a
P
HDCP
8.8 - 11.6 11 360 567 (5.0) 1.00 1.00
< 8.8 5 442 250 (4.6) 0.92 (0.79 - 1.07) 0.263 0.98 (0.84 - 1.14) 0.766
> 11.6 5 481 388 (7.1) 1.45 (1.27 - 1.66) <0.001 1.34 (1.17 - 1.53) <0.001
Gestational hypertension
8.8 - 11.6 11 008 215 (2.0) 1.00 1.00
< 8.8 5 303 111 (2.1) 1.07 (0.85 - 1.35) 0.550 1.13 (0.89 - 1.42) 0.321
> 11.6 5 243 150 (2.9) 1.48 (1.20 - 1.83) <0.001 1.39 (1.13 - 1.72) 0.002
Preeclampsia-eclampsia
8.8 - 11.6 11 145 352 (3.2) 1.00 1.00
< 8.8 5 331 139 (2.6) 0.82 (0.67 - 1.00) 0.052 0.88 (0.72 - 1.07) 0.206
> 11.6 5 331 238 (4.5) 1.43 (1.21 - 1.70) <0.001 1.34 (1.13 - 1.59) 0.001

表6

妇女孕前体重指数随分娩年份的变化[n(%)]"

Year of delivery n Underweight Normal Overweight Obesity Pa
2016 7 216 790 (10.9) 4 596 (63.7) 1 353 (18.8) 477 (6.6) 0.651
2017 7 677 786 (10.2) 4 788 (62.4) 1 644 (21.4) 459 (6.0)
2018 7 390 764 (10.3) 4 695 (63.5) 1 504 (20.4) 427 (5.8)
Total 22 283 2 340 (10.5) 14 079 (63.2) 4 501 (20.2) 1 363 (6.1)

表7

孕前BMI不同的妇女HDCP发病率及孕早期血清VE浓度水平"

Pre-pregnant BMI n HDCP VE concentration/(mg/L)
Incidence (n, %)a AOR (95%CI)b Median (P25 - P75) Pc Pd Pe
Underweight 2 340 62 (2.6) 0.64 (0.49 - 0.83) 9.8 (8.5 - 11.2) <0.001 <0.001 -
Normal 14 079 568 (4.0) 1.00 10.0 (8.7 - 11.5) - -
Overweight 4 501 374 (8.3) 2.15 (1.87 - 2.47) 10.4 (9.1 - 12.0) <0.001 0.723
Obesity 1 363 201 (14.7) 4.12 (3.46 - 4.91) 10.5 (9.1 - 12.2) <0.001
All participants 22 283 1 205 (5.4) - 10.1 (8.8 - 11.6) - -

图2

妇女孕早期血清VE水平与HDCP发病率关系的粗OR值及其95%CI(n = 22 283)"

图3

妇女孕早期血清VE水平与HDCP发病率关系的调整后OR值及95%CI(n = 22 283)"

[1] 谢幸, 苟文丽. 妇产科学[M]. 8版. 北京: 人民卫生出版社, 2013: 42, 64.
[2] 中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华围产医学杂志, 2016,19(3):161-169.
[3] Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis[J]. Hypertens Res, 2017,40(3):213-220.
pmid: 27682655
[4] Ye C, Ruan Y, Zou L, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes[J]. PLoS One, 2014,9(6):e100180.
[5] You SH, Cheng PJ, Chung TT, et al. Population-based trends and risk factors of early- and late-onset preeclampsia in Taiwan 2001—2014[J]. BMC Pregnancy Childbirth, 2018,18(1):199.
pmid: 29855344
[6] Paré E, Parry S, McElrath TF, et al. Clinical risk factors for preeclampsia in the 21st century[J]. Obstet Gynecol, 2014,124(4):763-770.
[7] Redman CW, Sargent IL. Latest advances in understanding preeclampsia[J]. Science, 2005,308(5728):1592-1594.
pmid: 15947178
[8] 殷为, 钟梅. 妊娠期高血压疾病的病因、预测及诊疗进展[J]. 实用医学杂志, 2016,32(11):1887-1890.
[9] 孙长颢. 营养与食品卫生学[M]. 8版. 北京: 人民卫生出版社, 2017: 93-95, 215.
[10] 郭方, 李笑天. 叶酸及多种维生素的补充对妊娠期高血压疾病的预防作用[J]. 中国实用妇科与产科杂志, 2014,30(8):592-596.
[11] Rumbold A, Ota E, Hori H, et al. Vitamin E supplementation in pregnancy[J]. Cochrane Database Syst Rev, 2015(9): CD004069.
[12] Zhang C, Williams MA, Sanchez SE, et al. Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women[J]. Am J Epidemiol, 2001,153(6):572-580.
pmid: 11257065
[13] Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension[J]. N Engl J Med, 2010,362(14):1282-1291.
[14] Poston L, Briley AL, Seed PT, et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial[J]. Lancet, 2006,367(9517):1145-1154.
[15] Rajasingam D, Seed PT, Briley AL, et al. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women[J]. Am J Obstet Gynecol, 2009,200(4):395.
pmid: 19200933
[16] 康忠春, 陈远兰, 邹余粮. 妊娠子痫前期孕妇维生素A、E水平及其影响因素分析[J]. 临床医学研究与实践, 2018,3(30):142-144.
[17] 张翠, 靳颖, 杨洁, 等. 河北省产妇2016年妊娠期高血压疾病患病情况分析[J]. 中国公共卫生, 2018,34(10):1395-1397.
[18] 牛影, 徐叶清, 郝加虎, 等. 马鞍山市妇女孕前体质指数和孕期增重与妊娠期高血压疾病的队列研究[J]. 卫生研究, 2016,45(2):205-210.
[19] 申南, 陆娣, 郑春梅, 等. 常规保健下不同年龄段孕妇妊娠早期血清维生素A、E水平分析[J]. 中国妇产科临床杂志, 2018,19(4):356-358.
[20] 闫明, 张雯, 刘凯波, 等. 北京地区2010年—2017年增补叶酸预防神经管缺陷工作效果分析[J]. 中国优生与遗传杂志, 2019,27(3):339-341.
[21] Schiff E, Friedman SA, Stampfer M, et al. Dietary consumption and plasma concentrations of vitamin E in pregnancies complicated by preeclampsia[J]. Am J Obstet Gynecol, 1996,175(4 Pt 1):1024-1028.
[22] Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies[J]. BMJ, 2016,353:i1753.
pmid: 27094586
[23] Rumbold AR, Crowther CA, Haslam RR, et al. Vitamins C and E and the risks of preeclampsia and perinatal complications[J]. N Engl J Med, 2006,354(17):1796-1806.
[24] Bowman BA, Russell RM. 现代营养学[M]. 8版. 荫士安,汪之顼, 译. 北京: 化学工业出版社, 2004: 195.
[25] Karpińska J, Mikołuć B, Motkowski R, et al. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma [J]. J Pharm Biomed Anal, 2006,42(2):232-236.
[26] 马蕊, 刘建蒙, 李松, 等. 浙江省嘉兴地区妊娠高血压综合征发病状况研究[J]. 中华流行病学杂志, 2005,26(12):960-963.
[27] Yusuf H, Subih HS, Obeidat BS, et al. Associations of macro and micronutrients and antioxidants intakes with preeclampsia: A case-control study in Jordanian pregnant women[J]. Nutr Metab Car-diovasc Dis, 2019,29(5):458-466.
[28] 孟凡文, 陈森, 刘亚山, 等. 河北省5县区妊娠期高血压疾病的发病情况及危险因素分析[J]. 中国生育健康杂志, 2015,26(2):112-115.
[1] 郭洪萍,赵艾,薛勇,马良坤,张玉梅,王培玉. 孕期营养素摄入与妊娠期糖尿病孕妇血糖控制效果的相关性研究[J]. 北京大学学报(医学版), 2021, 53(3): 467-472.
[2] 宋沁峰,李宏田,杨静,原鹏波,程志浩,刘建蒙,赵扬玉. 双胎妊娠孕早期甲状腺功能及其与早产的关联性[J]. 北京大学学报(医学版), 2021, 53(3): 473-478.
[3] 刘晓强,杨洋,周建锋,刘建彰,谭建国. 640例单牙种植术对血压和心率影响的队列研究[J]. 北京大学学报(医学版), 2021, 53(2): 390-395.
[4] 郑鸿尘,薛恩慈,王雪珩,陈曦,王斯悦,黄辉,江锦,叶莺,黄春兰,周筠,高文静,余灿清,吕筠,吴小玲,黄小明,曹卫华,严延生,吴涛,李立明. 基于大家系设计的静息心率与常见慢性病双表型遗传度估计[J]. 北京大学学报(医学版), 2020, 52(3): 432-437.
[5] 杨航,杨林承,张瑞涛,凌云鹏,葛庆岗. 合并高血压、冠心病、糖尿病的新型冠状病毒肺炎患者发生病死的危险因素分析[J]. 北京大学学报(医学版), 2020, 52(3): 420-424.
[6] 唐迅,张杜丹,刘晓非,刘秋萍,曹洋,李娜,黄少平,窦会东,高培,胡永华. China-PAR脑卒中模型在北方农村人群中预测脑卒中发病风险的应用[J]. 北京大学学报(医学版), 2020, 52(3): 444-450.
[7] 刘欢,何映东,刘金波,黄薇,赵娜,赵红薇,周晓华,王宏宇. 血管健康指标对新发心脑血管事件的预测价值:北京血管健康分级标准的初步验证[J]. 北京大学学报(医学版), 2020, 52(3): 514-520.
[8] 刘颖,曾祥柱,王筝,张函,王希林,袁慧书. 三维动脉自旋标记技术评价抑郁合并高血压患者脑血流灌注[J]. 北京大学学报(医学版), 2019, 51(2): 260-264.
[9] 李记,郑莉,石连杰,徐婧,舒建龙,张学武. 可溶性内皮糖蛋白在抗磷脂综合征患者的血清水平及临床意义[J]. 北京大学学报(医学版), 2018, 50(6): 1027-1032.
[10] 郭晓玥,邵珲,赵扬玉. 系统性红斑狼疮患者孕期并发肺动脉高压1例[J]. 北京大学学报(医学版), 2018, 50(5): 928-931.
[11] 林鸿波,陈奕,沈鹏,李小勇,司亚琴,张杜丹,唐迅,高培. 社区糖尿病患者慢性肾脏病的发病率及其危险因素[J]. 北京大学学报(医学版), 2018, 50(3): 416-421.
[12] 孙颖,靳蕾. 中国北方3县妊娠妇女血液锰浓度及其影响因素[J]. 北京大学学报(医学版), 2018, 50(3): 463-468.
[13] 王莎,张龑,赵杨玉,卢珊. 宫角妊娠2例[J]. 北京大学学报(医学版), 2018, 50(3): 576-579.
[14] 刘雪芹, 闫辉, 邱建星, 张春雨, 齐建光, 张欣, 肖慧捷, 杨艳玲, 陈永红, 杜军保. 甲基丙二酸尿症相关肺高血压临床特点与基因突变[J]. 北京大学学报(医学版), 2017, 49(5): 768-777.
[15] 唐迅,张杜丹,何柳,曹洋,王晋伟,李娜,黄少平,窦会东,高培,胡永华. China-PAR模型在北方农村人群中预测动脉粥样硬化性心血管疾病发病风险的应用[J]. 北京大学学报(医学版), 2017, 49(3): 439-445.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张三. 中文标题测试[J]. 北京大学学报(医学版), 2010, 42(1): 1 -10 .
[2] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报(医学版), 2009, 41(2): 188 -191 .
[3] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[4] 张燕, 韩志慧, 钟延丰, 王盛兰, 李玲玲, 郑丹枫. 骨骼肌活组织检查病理诊断技术的改进及应用[J]. 北京大学学报(医学版), 2009, 41(4): 459 -462 .
[5] 林红, 王玉凤, 吴野平. 学校生活技能教育对小学三年级学生行为问题影响的对照研究[J]. 北京大学学报(医学版), 2007, 39(3): 319 -322 .
[6] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[7] 李岳玲, 钱秋瑾, 王玉凤. 儿童注意缺陷多动障碍成人期预后及其预测因素[J]. 北京大学学报(医学版), 2007, 39(3): 337 -340 .
[8] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[9] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 346 -350 .
[10] 张宏文, 丁洁, 王芳, 杨惠霞. 一例X连锁Alport综合征女性妊娠期随访[J]. 北京大学学报(医学版), 2007, 39(4): 351 -354 .